World AIDS Day, which falls every year on December 1, serves as a reminder that while significant progress has been made in the global battle against HIV/AIDS, there is still much more to be done and we must recommit to the goal of Getting to Zero.
Johnson & Johnson, driven by our purpose of caring, remains committed to the prevention, detection, education and treatment of HIV/AIDS. This year, we created a four-part blog series to provide a glimpse of these efforts and some of the individuals leading them:
- The Fight Against Pediatric HIV and AIDS Goes On
- World AIDS Day Reflection
- World AIDS Day: Working to Ensure No One is Left Behind
- Collaboration at the Heart of Our HIV/AIDS Response in China
Above all, ending pediatric AIDS is one of our top priorities. With timely access to quality life-saving antiretroviral drugs, it is possible to stop new HIV infections among children and keep their mothers alive. But in the developing world that is often not the case. Approximately half of HIV-positive pregnant women do not receive any medication or information on how to prevent transmission to their infants.
In 2014, Janssen, the Pharmaceutical Companies of Johnson & Johnson, launched New Horizons Advancing Pediatric HIV Treatment, a drug donation program to expand access to the company’s approved HIV medicines. This initiative is one small piece of a much larger effort, and Johnson & Johnson is committed to doing our part to bring the hope of a full and productive life to young people living with HIV to reality.